SMTL ID : 7qi0.1 (1 other biounit)

Crystal structure of KLK6 in complex with compound DKFZ918

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.88 Å

Oligo State

monomer

Ligands

1 x C9I: (5~{R})-3-(6-carbamimidoylpyridin-3-yl)-~{N}-[(1~{S})-1-naphthalen-1-ylpropyl]-2-oxidanylidene-1,3-oxazolidine-5-carboxamide(Non-covalent)

C9I.1: 17 residues within 4Å: Chain A: L.24, L.25, C.26, H.41, F.130, D.170, S.171, Q.173, G.174, S.176, S.191, W.192, G.193, N.194, I.195, C.197, G.204 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.25, A:F.130, A:Q.173 Hydrogen bonds: A:D.170, A:S.171, A:Q.173, A:G.174, A:S.176, A:N.194 Water bridges: A:S.176, A:N.194, A:V.205, A:V.205

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baumann, A. et al., Scalable synthesis and structural characterization of reversible KLK6 inhibitors. Rsc Adv (2022)

Release Date

2022-11-23

Peptides

Kallikrein-6: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Kallikrein-6

Related Entries With Identical Sequence